Cargando…

Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score

Background: Triple fixed-dose combination (FDC) therapy is recommended in severe chronic obstructive pulmonary disease (COPD) patients experiencing frequent exacerbations and/or symptoms not controlled by dual FDCs. Since no randomized controlled trials (RCTs) have directly compared the different in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rogliani, Paola, Ora, Josuel, Cavalli, Francesco, Cazzola, Mario, Calzetta, Luigino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369741/ https://www.ncbi.nlm.nih.gov/pubmed/35956108 http://dx.doi.org/10.3390/jcm11154491

Ejemplares similares

Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile
por: Rogliani, Paola, et al.
Publicado: (2022)

The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis
por: Rogliani, Paola, et al.
Publicado: (2017)

Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis
por: Rogliani, Paola, et al.
Publicado: (2019)

LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment
por: Calzetta, Luigino, et al.
Publicado: (2017)

Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement
por: Manzetti, Gian Marco, et al.
Publicado: (2023)

Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease
por: Ora, Josuel, et al.
Publicado: (2020)

The Time Course of Pulmonary Function Tests in COPD Patients with Different Levels of Blood Eosinophils
por: Rogliani, Paola, et al.
Publicado: (2016)

The future of inhalation therapy in chronic obstructive pulmonary disease
por: Cazzola, Mario, et al.
Publicado: (2022)

Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences
por: Cazzola, Mario, et al.
Publicado: (2023)

Sex differences in adult asthma and COPD therapy: a systematic review
por: Rogliani, Paola, et al.
Publicado: (2022)

Hyperglycaemia and Chronic Obstructive Pulmonary Disease
por: Cazzola, Mario, et al.
Publicado: (2023)

Clinical Interpretation of Efficacy Outcomes in Pharmacological Studies on Triple Fixed-Dose Combination Therapy for Uncontrolled Asthma: Assessment of IRIDIUM and ARGON Studies
por: Rogliani, Paola, et al.
Publicado: (2022)

Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
por: Cazzola, Mario, et al.
Publicado: (2019)

LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review
por: Rogliani, Paola, et al.
Publicado: (2018)

Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells
por: Cazzola, Mario, et al.
Publicado: (2016)

Airflow obstruction: is it asthma or is it COPD?
por: Rogliani, Paola, et al.
Publicado: (2016)

An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease
por: Cazzola, Mario, et al.
Publicado: (2021)

The clinical use of regenerative therapy in COPD
por: Lipsi, Roberto, et al.
Publicado: (2014)

Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation
por: Cazzola, Mario, et al.
Publicado: (2017)

Beyond Dual Bronchodilation – Triple Therapy, When and Why
por: Cazzola, Mario, et al.
Publicado: (2022)

Strength of association between comorbidities and asthma: a meta-analysis
por: Rogliani, Paola, et al.
Publicado: (2023)

New Avenues for Phosphodiesterase Inhibitors in Asthma
por: Matera, Maria Gabriella, et al.
Publicado: (2021)

Treatable Mechanisms in Asthma
por: Cazzola, Mario, et al.
Publicado: (2021)

Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis
por: Calzetta, Luigino, et al.
Publicado: (2022)

SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines
por: Rogliani, Paola, et al.
Publicado: (2021)

Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
por: Cazzola, Mario, et al.
Publicado: (2015)

Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine
por: Rogliani, Paola, et al.
Publicado: (2019)

Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy
por: Cazzola, Mario, et al.
Publicado: (2020)

Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review
por: Matera, Maria Gabriella, et al.
Publicado: (2020)

Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to Patients
por: Calzetta, Luigino, et al.
Publicado: (2019)

Editorial overview: Respiratory: Pulmonary pharmacology–The emergence of new treatments in pulmonary medicine is finally providing real therapeutic perspectives
por: Cazzola, Mario, et al.
Publicado: (2021)

Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways
por: Calzetta, Luigino, et al.
Publicado: (2018)

Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine
por: Calzetta, Luigino, et al.
Publicado: (2017)

Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent
por: Cazzola, Mario, et al.
Publicado: (2020)

Effects of SARS-CoV-2 Infection on Pulmonary Function Tests and Exercise Tolerance
por: Ora, Josuel, et al.
Publicado: (2022)

Guidance on nebulization during the current COVID-19 pandemic
por: Cazzola, Mario, et al.
Publicado: (2021)

The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma
por: Calzetta, Luigino, et al.
Publicado: (2023)

Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
por: Matera, Maria Gabriella, et al.
Publicado: (2015)

Use of Thiols in the Treatment of COVID-19: Current Evidence
por: Cazzola, Mario, et al.
Publicado: (2021)

Efficacy and safety profile of xanthines in COPD: a network meta-analysis
por: Cazzola, Mario, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_25gqba3sg5a8dtarg60d0lqbsk